We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IQV Q1 Earnings Beat on Commercial Solutions Strength
Read MoreHide Full Article
Key Takeaways
IQV Q1 adjusted EPS of $2.90 beat the estimate of $2.83; revenues of $4.15B rise 8.4% y/y.
IQVIA Commercial Solutions revenues were $1.75B, up 11.6% y/y, led by patient and analytics demand.
IQV R&D Solutions posted $34.2B in backlog; $2.5B in net bookings and 1.04X book-to-bill in Q1.
IQVIA Holdings Inc. (IQV - Free Report) has posted first-quarter 2026 adjusted earnings of $2.90 per share, beating the Zacks Consensus Estimate of $2.83 by 2.5%. Revenues came in at $4.15 billion, topping the consensus mark of $4.08 billion by 1.6%.
Results improved year over year, with adjusted diluted earnings per share up 7.4% and revenues rising 8.4%. The quarter benefited from better-than-expected organic growth across the business, supported by strengthening demand indicators, including a $34.2-billion contracted backlog in the Research & Development Solutions business.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
IQV's Commercial Solutions Growth Leads the Quarter
Commercial Solutions delivered the sharpest top-line momentum in the quarter. Segmental revenues were $1.75 billion, increasing 11.6% on a reported basis and 8.5% at constant currency.
Management highlighted notable strength across patient solutions, analytics and consulting, and commercial engagement services. The company also pointed to growing traction in AI-enabled offerings, suggesting product innovation is contributing to sales performance alongside broader market demand.
Research & Development Solutions revenues were $2.40 billion, up 6.2% on a reported basis and 4.2% at constant currency. Excluding reimbursed expenses, R&D Solutions revenues increased 6.6% reported, reflecting healthier underlying service growth.
Beyond reported revenues, the bookings picture remained constructive. Net new bookings were $2.5 billion, with a first-quarter book-to-bill ratio of 1.04X and a trailing-12-month ratio of 1.11X. The company also expects $8.9 billion of contracted work to convert into revenues over the next 12 months, indicating 7.6% year-over-year growth, offering a clearer line of sight into near-term demand.
IQV's Profit Engine Supports Cash Conversion
Profitability remained solid in the quarter, with adjusted EBITDA of $932 million, up 5.5% year over year. GAAP net income attributable to IQVIA was $274 million, reflecting continued earnings power alongside ongoing non-GAAP addbacks tied to restructuring and acquisition-related items.
Cash generation was a key positive. The operating cash flow rose 9% year over year to $618 million, while the free cash flow increased 15% to $491 million. Notably, the free cash flow equaled 100% of adjusted net income, underscoring strong conversion and disciplined working-capital management.
IQVIA's 2026 Outlook Mixes Stability With Upside
IQVIA reaffirmed its 2026 revenue guidance of $17.15-$17.35 billion and maintained its adjusted EBITDA outlook of $3.975-$4.025 billion, signaling confidence in the demand environment and delivery execution across both segments.
The company raised its full-year adjusted diluted earnings per share forecast to $12.65-$12.95, pointing to better operating performance than previously expected. The outlook assumes 150 basis points of acquisition contribution and an estimated 100 basis points of foreign-exchange tailwind, based on exchange rates as of May 4, 2026.
IQV's Balance Sheet & Capital Returns Stay in Focus
IQVIA ended the quarter with $1.95 billion in cash and cash equivalents, and total debt of $15.83 billion, translating to net debt of $13.89 billion. The net leverage ratio was 3.62X trailing 12-month adjusted EBITDA, providing context for financial flexibility as the company balances investment needs with shareholder returns.
Capital allocation remained active. IQVIA repurchased $552 million worth of common stock during the quarter and had $1.22 billion remaining under its authorization as of March 31, 2026, reinforcing management’s continued emphasis on returning capital while maintaining leverage within its targeted framework.
Verisk Analytics, Inc. (VRSK - Free Report) reported first-quarter 2026 diluted adjusted earnings per share of $1.82, beating the Zacks Consensus Estimate of $1.76 by 3.4%. The figure increased 5.2% from the year-ago quarter.
Revenues came in at $782.6 million, topping the consensus mark of $775.9 million by 0.9% and rising 3.9% year over year. Organic constant-currency revenue growth was 4.7%, supported by continued momentum across the Insurance business.
Automatic Data Processing, Inc. (ADP - Free Report) posted third-quarter fiscal 2026 adjusted earnings per share of $3.37, beating the Zacks Consensus Estimate of $3.28 by 2.7%. The metric increased 10.1% from the year-ago quarter.
Total revenues came in at $5.94 billion, topping the consensus mark of $5.86 billion by 1.4% and rising 7% year over year. Operationally, Employer Services client revenue retention and overall client satisfaction reached record highs for the third quarter.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
IQV Q1 Earnings Beat on Commercial Solutions Strength
Key Takeaways
IQVIA Holdings Inc. (IQV - Free Report) has posted first-quarter 2026 adjusted earnings of $2.90 per share, beating the Zacks Consensus Estimate of $2.83 by 2.5%. Revenues came in at $4.15 billion, topping the consensus mark of $4.08 billion by 1.6%.
Results improved year over year, with adjusted diluted earnings per share up 7.4% and revenues rising 8.4%. The quarter benefited from better-than-expected organic growth across the business, supported by strengthening demand indicators, including a $34.2-billion contracted backlog in the Research & Development Solutions business.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote
IQV's Commercial Solutions Growth Leads the Quarter
Commercial Solutions delivered the sharpest top-line momentum in the quarter. Segmental revenues were $1.75 billion, increasing 11.6% on a reported basis and 8.5% at constant currency.
Management highlighted notable strength across patient solutions, analytics and consulting, and commercial engagement services. The company also pointed to growing traction in AI-enabled offerings, suggesting product innovation is contributing to sales performance alongside broader market demand.
IQVIA's R&D Franchise Shows Healthier Demand Signals
Research & Development Solutions revenues were $2.40 billion, up 6.2% on a reported basis and 4.2% at constant currency. Excluding reimbursed expenses, R&D Solutions revenues increased 6.6% reported, reflecting healthier underlying service growth.
Beyond reported revenues, the bookings picture remained constructive. Net new bookings were $2.5 billion, with a first-quarter book-to-bill ratio of 1.04X and a trailing-12-month ratio of 1.11X. The company also expects $8.9 billion of contracted work to convert into revenues over the next 12 months, indicating 7.6% year-over-year growth, offering a clearer line of sight into near-term demand.
IQV's Profit Engine Supports Cash Conversion
Profitability remained solid in the quarter, with adjusted EBITDA of $932 million, up 5.5% year over year. GAAP net income attributable to IQVIA was $274 million, reflecting continued earnings power alongside ongoing non-GAAP addbacks tied to restructuring and acquisition-related items.
Cash generation was a key positive. The operating cash flow rose 9% year over year to $618 million, while the free cash flow increased 15% to $491 million. Notably, the free cash flow equaled 100% of adjusted net income, underscoring strong conversion and disciplined working-capital management.
IQVIA's 2026 Outlook Mixes Stability With Upside
IQVIA reaffirmed its 2026 revenue guidance of $17.15-$17.35 billion and maintained its adjusted EBITDA outlook of $3.975-$4.025 billion, signaling confidence in the demand environment and delivery execution across both segments.
The company raised its full-year adjusted diluted earnings per share forecast to $12.65-$12.95, pointing to better operating performance than previously expected. The outlook assumes 150 basis points of acquisition contribution and an estimated 100 basis points of foreign-exchange tailwind, based on exchange rates as of May 4, 2026.
IQV's Balance Sheet & Capital Returns Stay in Focus
IQVIA ended the quarter with $1.95 billion in cash and cash equivalents, and total debt of $15.83 billion, translating to net debt of $13.89 billion. The net leverage ratio was 3.62X trailing 12-month adjusted EBITDA, providing context for financial flexibility as the company balances investment needs with shareholder returns.
Capital allocation remained active. IQVIA repurchased $552 million worth of common stock during the quarter and had $1.22 billion remaining under its authorization as of March 31, 2026, reinforcing management’s continued emphasis on returning capital while maintaining leverage within its targeted framework.
IQV carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot
Verisk Analytics, Inc. (VRSK - Free Report) reported first-quarter 2026 diluted adjusted earnings per share of $1.82, beating the Zacks Consensus Estimate of $1.76 by 3.4%. The figure increased 5.2% from the year-ago quarter.
Revenues came in at $782.6 million, topping the consensus mark of $775.9 million by 0.9% and rising 3.9% year over year. Organic constant-currency revenue growth was 4.7%, supported by continued momentum across the Insurance business.
Automatic Data Processing, Inc. (ADP - Free Report) posted third-quarter fiscal 2026 adjusted earnings per share of $3.37, beating the Zacks Consensus Estimate of $3.28 by 2.7%. The metric increased 10.1% from the year-ago quarter.
Total revenues came in at $5.94 billion, topping the consensus mark of $5.86 billion by 1.4% and rising 7% year over year. Operationally, Employer Services client revenue retention and overall client satisfaction reached record highs for the third quarter.